Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Group Size in Basic Life Support (BLS) Courses

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03773861
Recruitment Status : Recruiting
First Posted : December 12, 2018
Last Update Posted : January 29, 2020
Sponsor:
Information provided by (Responsible Party):
University Hospital Inselspital, Berne

Brief Summary:
Basic Life Support (BLS) is important for outcome in cardiac arrest.Therefore, it is crucial to improve the quality of education in resuscitation training. Better training will eventually lead to more effective CPR skills in course participants. BLS courses in both international resuscitation associations (European Resuscitation Council and American Heart Association are typically taught in small groups of 6 participants. In reality group sizes of up to 10 participants are used, because these courses are highly demanded and cost intensive. There is no evidence for the effective group size to be clinical and cost effective. Therefore the investigators perform this prospective study to determine the maximum number of participants an instructor can oversee without missing more than 20% of errors made during an instructional BLS session.

Condition or disease Intervention/treatment Phase
Educational Problems Resuscitation Other: errors made in one BLS session Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 50 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Other
Official Title: Determining a Threshold for the Clinical and Cost-effectiveness of Group Size During Basic Life Support Courses
Actual Study Start Date : December 10, 2018
Estimated Primary Completion Date : May 31, 2020
Estimated Study Completion Date : August 31, 2020

Arm Intervention/treatment
Participants
Active BLS- Instructors at the Bern Simulation and CPR- Center (BeSiC), at the Bern University Hospital, Bern, Switzerland. Participants have to oversee a BLS instructional session, where standardized errors are performed by trained volunteers.
Other: errors made in one BLS session
BLS instructors have to oversee a standardized BLS training session, where standardized errors are made by trained volunteers.




Primary Outcome Measures :
  1. The threshold of number of course participants in a BLS educational session [ Time Frame: BLS educational session 10 minutes ]
    How many volunteers can be overseen by one instructor who still is able to correctly identify and correct serious BLS errors of all course participants.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 70 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Active BLS- Instructors at the Bern Simulation and CPR-Center (BeSiC), at the Bern University Hospital, Bern, Switzerland

Exclusion Criteria:

  • Decline to participate

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03773861


Contacts
Layout table for location contacts
Contact: Sabine Nabecker, M.D. +4131 632 3965 sabine.nabecker@insel.ch

Locations
Layout table for location information
Switzerland
University Hospital Bern Recruiting
Bern, Switzerland
Contact: Sabine Nabecker, M.D.    +4131 632 3965    sabine.nabecker@insel.ch   
Sponsors and Collaborators
University Hospital Inselspital, Berne
Investigators
Layout table for investigator information
Principal Investigator: Sabine Nabecker, M.D. University Hospital Bern, Bern, Switzerland
Publications:
Layout table for additonal information
Responsible Party: University Hospital Inselspital, Berne
ClinicalTrials.gov Identifier: NCT03773861    
Other Study ID Numbers: Req- 2017- 00577
First Posted: December 12, 2018    Key Record Dates
Last Update Posted: January 29, 2020
Last Verified: January 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No